Trial intelligence / Profile preview

Atorvastatin effect on mean platelet volume in untreated hypercholesterolemia

IRCT201706089014N168Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of atorvastatin in hypercholesterolemia, sponsored by Hamadan University of Medical Sciences. Primary endpoint: Mean platelet volume change. Started Dec 2016; status: completed.

02

Drugs

atorvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on IRCT201706089014N168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201706089014N168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call